Anchor Drugs Ii Headquarters
Looking for information about Anchor Drugs Ii Headquarters? The links below have collected all the necessary data.
Anchor Drugs Ii in Redwood City, California - Pharmacy ...
- https://npino.com/pharmacy/1790997153-anchor-drugs-ii/
- The current location address for Anchor Drugs Ii is 730 Woodside Rd, , Redwood City, California and the contact number is 650-360-5357 and fax number is 650-360-5325. The mailing address for Anchor Drugs Ii is 730 Woodside Rd, , Redwood City, California - 94061-3749 (mailing address contact number - 650-360-5357). JAJCO INC.Pharmacy Name: Anchor Drugs Ii
Home Anchor Drugs Pharmacy
- https://www.anchorpharmacy.com/
- Anchor Drugs Pharmacy 161 S. Spruce Ave. • S. San Francisco, CA 94080 Ph: 650.360.5300 • Fax: 650.360.5301. Palliative Care please call 650.360.5358 or Fax 650.583.8408
Contact Us Anchor Drugs Pharmacy
- https://www.anchorpharmacy.com/contact_us.html
- Anchor Drugs Pharmacy 161 S. Spruce Ave. • S. San Francisco, CA 94080 Ph: 650.360.5300 • Fax: 650.360.5301. Palliative Care please call 650.360.5358 or Fax 650.583.8408
Pharmacy, Anchor Pharmacy and Medical Supplies ...
- http://www.anchorrx.com/
- Let Anchor Pharmacy & Medical Supplies be there to support you and your loved ones. No national chain drugstore or other pharmacy comes close to matching Anchor's high level of personal service and professional expertise. Our pharmacists, certified fitters and respiratory therapists take the extra time necessary to understand your special ...
Anchor Drugs Iii in South San Francisco, California ...
- https://npino.com/pharmacy/1427297498-anchor-drugs-iii/
- Anchor Drugs Iii (JAJCO INC.) is a Community/Retail Pharmacy in South San Francisco, California. The NPI Number for Anchor Drugs Iii is 1427297498. The current location address for Anchor Drugs Iii is 161 S Spruce Ave, , South San Francisco, California and the contact number is 650-360-5357 and fax number is 650-360-5301. The mailing address for Anchor Drugs Iii is 161 S Spruce Ave, , South San …Pharmacy Name: Anchor Drugs Iii
Data from Oncopeptides Clinical Trials HORIZON and ANCHOR ...
- https://www.oncopeptides.com/en/media/press-releases/data-from-oncopeptides-clinical-trials-horizon-and-anchor-evaluating-melflufen-in-rrmm-selected-for-presentation-at-the-aacr-annual-meeting
- Feb 27, 2019 · Stockholm — 27 February 2019 — Oncopeptides AB (Nasdaq Stockholm: ONCO) today announced that data from its Phase II HORIZON study and Phase I/II ANCHOR study evaluating the company’s novel candidate melflufen, a peptide-conjugated alkylator belonging to the novel class of peptidase enhanced compounds, have been selected as poster presentations at the 2019 American …
Have you found Anchor Drugs Ii Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.